Molecular Pharmaceutics · 2015 · 36 citations · 25 references
Natural SciencesChemistryPharmaceutical AnalysisNanomaterialsPhysical ChemistrySpectroscopyCrystal ChemistryNanomaterial CharacterizationNanoparticle CharacterizationOptical SpectroscopyRaman SpectroscopyActive Ingredient IdentificationActive Ingredient QuantificationConfocal Raman SpectroscopyCrystal Size AnalysisCrystallinityCrystallinity DeterminationRaman MicroscopyRaman Spectra
Second harmonic generation (SHG) microscopy was used to rapidly identify regions of interest for localized confocal Raman spectroscopy measurements in order to quantify crystallinity within lyophilized Abraxane powder (protein bound paclitaxel for injectable suspension). Water insoluble noncentrosymmetric crystalline particles ranging from ∼1 to 120 μm were identified by SHG, with wide variability in crystal size and frequency observed between several batches of Abraxane. By targeting the Raman analysis to these localized regions identified by SHG, the required measurement time was decreased over 2 orders of magnitude, from 8 h to 2 s. Experimental Raman spectra of SHG active domains in Abraxane were in good agreement with experimental spectra of pure crystalline paclitaxel. These collective results are consistent with up to 30% of the active ingredient being present as poorly soluble crystalline particulates in some batches of Abraxane.
25
Solubility Advantage of Amorphous Drugs and Pharmaceutical Cocrystals
N.J. Babu, Ashwini Nangia · Crystal Growth & Design · 2011 · 986 citations
Pharmacy, Chemistry, Pharmacology +17
Dissolution and Precipitation Behavior of Amorphous Solid Dispersions
David E. Alonzo, Yi Gao, Deliang Zhou et al. · Journal of Pharmaceutical Sciences · 2011 · 278 citations